NCT00204633
- Conditions
- Dysgerminoma, Germinoma, Neoplasms, +2 more
- Locations
-
- Medical Center II, University of Tuebingen Tübingen, Germany
Clinical trial condition
Dysgerminoma
Explore clinical trials studying Dysgerminoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Dysgerminoma trial results
Active, Not Recruiting
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
NCT03158064
- Conditions
- Dysgerminoma, Germ Cell Tumor, Germinoma, +8 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States